ENHANCED PROVIDES CLINICAL TRIAL UPDATE - FIRST OF ITS KIND STUDY CONTINUES WITH ATHLETES HEALTHY & SAFE TO COMPETE

Go back to ENHANCED PROVIDES CLINICAL TRIAL UPDATE - FIRST OF ITS KIND STUDY CONTINUES WITH ATHLETES HEALTHY & SAFE TO COMPETE
(NYSE: ENHA) Delayed: 3.92 --0 (-0%)
Previous Close $3.92    52 Week High
Open $3.92    52 Week Low
Day High $3.92    P/E N/A 
Day Low $3.92    EPS
Volume 110,605